In both mouse models, Foxp3+ Treg cell depletion by the in vivo administration of DT promotes the development of autoimmune disorders, albeit with differences in the severity of autoimmune symptoms [36, 69]. The gene discussed is FOXP3; the disease is Autoimmunity.